Toronto Stock Exchange (TSX) · SZLS.TO · ISIN CA8525403017
StageZero Life Sciences Ltd.
No trading activity has been reported for this listing since February 12, 2025. It may be delisted, halted or inactive.
0.0400 CAD
February 12, 2025
StageZero Life Sciences Ltd. (SZLS.TO) trades on the Toronto Stock Exchange and operates in the Medical - Diagnostics & Research industry. Its market capitalisation is approximately 4.94M CAD. The company reports around 40 employees. Its ISIN is CA8525403017. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.
Key facts
Exchange
Toronto Stock Exchange (TSX)
ISIN
CA8525403017
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
CA
Market cap
4.94M CAD
Employees
40
Previous close
0.04 CAD
Day range
0.04 – 0.04
52-week range
0.04 – 0.06
Volume
0
50-day average
0.04 CAD
200-day average
0.04 CAD
Asset type
Equity
About StageZero Life Sciences Ltd.
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Company websiteFrequently asked
- What is the SZLS.TO share price today?
- This page shows the latest available StageZero Life Sciences Ltd. (SZLS.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
- Where is StageZero Life Sciences Ltd. listed?
- StageZero Life Sciences Ltd. trades on the Toronto Stock Exchange under the symbol SZLS.TO, ISIN CA8525403017.
- How large is StageZero Life Sciences Ltd.?
- Its market capitalisation is approximately 4.94M CAD, based on the latest available price and share count from our data provider.
+
+
+
All StageZero Life Sciences Ltd. data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.
Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.